The first national correspondent for UCC Capital Corp. in the life sciences sector was announced last week as the firm moves into expansion mode, a rollout that also included the launch of a new Patent Royalty Trust, aimed at academia.

Robert D'Loren, UCC Capital's CEO, explained in an interview with ASR that his firm has five national correspondents and will add five additional regional correspondents, roles charged with fettering out opportunities across the U.S. for intellectual property monetizations and securitizations.

Subscribe Now

Access to a full range of industry content, analysis and expert commentary.

30-Day Free Trial

No credit card required. Access coverage of the securitization marketplace, including breaking news updated throughout the day.